{
    "clinical_study": {
        "@rank": "62247", 
        "arm_group": [
            {
                "arm_group_label": "Experimental group", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "Control group", 
                "arm_group_type": "Placebo Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate whether an Amitriptylin induced change in sleep\n      patterns can be conditioned according to learning theory in healthy participants."
        }, 
        "brief_title": "Pharmacological Conditioning of Sleep Patterns in Healthy Participants Using Amitriptylin", 
        "condition": "Healthy Participants", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  age between 18 years to 69 years\n\n          -  willingness to refrain from alcohol consumption throughout the study\n\n          -  regular sleeping habits\n\n          -  fluent in German language\n\n          -  is not dependent on driving to get to the study center\n\n          -  provide written informed consent\n\n          -  ability to understand the explanations and instructions given by the study physician\n             and the investigator\n\n        Exclusion Criteria:\n\n          -  Contraindications to study medication intake according to the information sheet for\n             health professionals (Summary of medicinal Product Characteristics, SmPC) assessed by\n             physical examination (including ECG) and medical history\n\n               -  allergies to amitriptyline hydrochloride or any of its ingredients\n\n               -  acute intoxication with alcohol, analgetics, hypnotics or any other psychotropic\n                  drug\n\n               -  urinary retention\n\n               -  delirium\n\n               -  untreated closed-angle glaucoma\n\n               -  prostatic hyperplasia\n\n               -  pyloric stenosis\n\n               -  paralytic ileus\n\n               -  suicidal thoughts\n\n               -  liver/ kidney/ pulmonary insufficiency\n\n               -  myasthenia gravis\n\n               -  hypokalemia\n\n               -  bradycardia\n\n               -  coronary heart disease, cardiac arrhythmias, long QT syndrome or other\n                  clinically relevant cardiac disorders\n\n               -  increased risk of seizures/ history of seizures\n\n               -  substance dependence syndrome/ history of substance dependence syndrome\n\n          -  Allergies to ingredients of placebo or novel-tasting drink (CS)\n\n          -  currently pregnant (verified by urine pregnancy test) or lactating\n\n          -  patients suffering from a mental disorder as verified by the International Diagnosis\n             Checklists (IDCL)\n\n          -  patients suffering from a medical condition (assessed by the study physician)\n\n          -  Concomitant medication interfering with study medication intake due to potential\n             interactions\n\n          -  participation in any other clinical trial 3 months prior to visit 1\n\n          -  employee of the Sponsor or the principal investigator"
            }, 
            "gender": "Both", 
            "maximum_age": "69 Years", 
            "minimum_age": "18 Years"
        }, 
        "firstreceived_date": "April 29, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02127736", 
            "org_study_id": "PSG40"
        }, 
        "intervention": [
            {
                "arm_group_label": "Experimental group", 
                "intervention_name": "Amitriptyline", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "Experimental group", 
                    "Control group"
                ], 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Amitriptyline", 
                "Amitriptyline, perphenazine drug combination"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 16, 2014", 
        "location": {
            "contact": {
                "email": "rief@staff.uni-marburg.de", 
                "last_name": "Winfried Rief, Prof. Dr.", 
                "phone": "+49-6421-28 23657"
            }, 
            "facility": {
                "address": {
                    "city": "Marburg", 
                    "country": "Germany", 
                    "state": "Hessen", 
                    "zip": "35032"
                }, 
                "name": "Department of Psychology, Philipps University Marburg"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Germany"
        }, 
        "official_title": "Pharmacological Conditioning of Sleep Patterns in Healthy Participants Using Amitriptylin", 
        "overall_contact": {
            "email": "rief@staff.uni-marburg.de", 
            "last_name": "Winfried Rief, Prof. Dr.", 
            "phone": "+49-6421-28 23657"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Germany: Philipps University Marburg"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "August 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "assessed by polysomnography", 
                "measure": "Objective Total Sleep Time", 
                "safety_issue": "No", 
                "time_frame": "5 nights during the study"
            }, 
            {
                "description": "assessed by polysomnography", 
                "measure": "Percentage of rapid eye movement (REM) sleep", 
                "safety_issue": "No", 
                "time_frame": "5 nights during the study"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02127736"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Philipps University Marburg Medical Center", 
            "investigator_full_name": "Winfried Rief", 
            "investigator_title": "Prof. Dr. Winfried Rief", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "source": "Philipps University Marburg Medical Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Winfried Rief", 
                "agency_class": "Other"
            }
        }, 
        "study_design": "N/A", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}